Breaking
European Research Revolution: Day 1 HighlightsRAPS Euro Convergence: Key Regulatory Updates - Day 1Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD
🇪🇺 EMA

Cancer Detection

Page 1 • 1 item

Unlock global cancer detection market insights. Discover novel diagnostics, regulatory pathways, and investment opportunities for pharma BD and investors.

GRAIL's Galleri Cancer Detection Test Shows Major Results in 174,000-Patient Studies at ASCO 2026
NewsCancer Detection/Early ScreeningApr 22, 2026

GRAIL's Galleri Cancer Detection Test Shows Major Results in 174,000-Patient Studies at ASCO 2026

GRAIL presents breakthrough NHS-Galleri and PATHFINDER 2 trial data for multi-cancer early detection test at ASCO 2026, covering 174,000+ participants.

Prof. Marcus Webb